Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product ...
Preliminary unaudited net revenues from global sales of IMCIVREE®(setmelanotide) of approximately $42 million for the fourth quarter of 2024 ...